Loading...

Our Financials

Overview

The St Vincent’s Health Australia Group generated an operating surplus of $50.46m for the year ended 30 June 2018 (2017: $67.33m) which represented 2.08% of total revenue (2017: 2.87%). Reserving a 2% operating surplus ensures that SVHA can continue to invest in patient care, research, technology and capital expenditure.

Operating surplus for the managed group has reduced by $16.9m due to the ramp up costs of new facilities, increased depreciation, and additional IT investments.

Total surplus for the managed group $62.6m reduced by $46.9 on last year (2017: $109.6m) with less capital funding income and no significant fair value gains in the current year.

The managed group net assets of $1.2bn (2017: $1.0bn) include an increase in property plant and equipment (strategic growth in facility network) and investments (aged care growth as reflected in accommodation bonds).

The statutory group has increased its net assets by $140.2m including recognition of two new controlled entities – the St Vincent’s Institute of Medical Research and the Victor Chang Cardiac Research Institute – which were transferred to the Group (Statutory group) following a change to their respective Constitutions.

$50.5 M

Operating surplus for the managed
group for the year ended 30 June 2018.

The statutory group has increased its
net assets by

$140 M

including recognition of two new
controlled entities due to membership
changes, Victor Chang and St Vincent’s
Institute of Medical Research.

$2.5 BN

Total revenue and other income
for the managed group.

$62.6 M

Total surplus for the managed group.

The managed group finished the
financial year with net assets of $1.2bn
an increase of

$159 M

through property plant and
equipment (strategic growth in
facility network) and investments
(aged care growth as reflected in
accommodation bonds).